Irritable Bowel Syndrome
To view the entire topic, please log in or purchase a subscription.
Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:
-- The first section of this topic is shown below --
Basics
Description
- A gastrointestinal (GI) disorder characterized by
- Chronic and/or recurrent abdominal pain or discomfort, bloating and distention, and alteration in bowel habits in the absence of an organic cause.
- May be characterized as diarrhea-predominant or constipation-predominant; may alternate between symptoms
- Synonym(s): spastic colon; irritable colon
Epidemiology
Irritable bowel syndrome (IBS) accounts for 30–50% of visits to gastroenterologists:
- Second only to upper respiratory infection as cause of lost workdays
Pooled estimate of 11% IBS prevalence internationally; ranges from South Asia (7%) to South America (21%); prevalence in North America is 12%.
- Predominant age: 20 to 39 years
- If age >50 years, consider other diagnoses.
- In the United States, female > male (3:1)
- More common in low socioeconomic communities
Etiology and Pathophysiology
- The etiology is unknown; associated with abnormalities of intestinal motility and enhanced sensitivity to visceral stimuli
- The trigger may be luminal or environmental.
- Evidence for the role of small intestinal bacterial overgrowth (SIBO) in IBS and association with antibiotic therapy is controversial; older age and female gender are predictors of SIBO in IBS patients.
- The role of food sensitivity, genetic, and psychosocial causes are also under active investigation.
- Increase in mast cell density and activity has been demonstrated on biopsy from terminal ileum, jejunum, colon in patients with IBS, and may correlate with visceral hypersensitivity (1).
- Current investigation is ongoing regarding low-grade mucosal and neuroinflammation, and the contribution of this inflammation in the dysregulation of the “brain-gut” axis (1).
- Four bowel patterns in the Rome IV classification:
- IBS-D (diarrhea predominant), IBS-C (constipation predominant), IBS-M (mixed diarrhea and constipation, IBS-U (unclassified-symptoms cannot be categorized into one of the three subtypes)
- The utility of subtyping has been questioned. Many patients change categories/subtypes over time.
Genetics
Unknown. IBS tracks in some families. Twin studies do not, however, show a clear genetic component.
Risk Factors
- Other family members with similar GI disorder
- History of childhood sexual abuse
- Sexual/domestic abuse (primarily in women)
- Depression
- Anxiety
- GI infection
Pediatric Considerations
No risk to mother or fetus
General Prevention
See “Diet.”
Commonly Associated Conditions
- Chronic migraine
- Fibromyalgia
- Chronic fatigue syndrome
- Sleep disorders
- Psychiatric disorders: major depression, anxiety, somatoform disorders, and posttraumatic stress
- Chronic pelvic pain
- Temporomandibular joint dysfunction
-- To view the remaining sections of this topic, please log in or purchase a subscription --
Basics
Description
- A gastrointestinal (GI) disorder characterized by
- Chronic and/or recurrent abdominal pain or discomfort, bloating and distention, and alteration in bowel habits in the absence of an organic cause.
- May be characterized as diarrhea-predominant or constipation-predominant; may alternate between symptoms
- Synonym(s): spastic colon; irritable colon
Epidemiology
Irritable bowel syndrome (IBS) accounts for 30–50% of visits to gastroenterologists:
- Second only to upper respiratory infection as cause of lost workdays
Pooled estimate of 11% IBS prevalence internationally; ranges from South Asia (7%) to South America (21%); prevalence in North America is 12%.
- Predominant age: 20 to 39 years
- If age >50 years, consider other diagnoses.
- In the United States, female > male (3:1)
- More common in low socioeconomic communities
Etiology and Pathophysiology
- The etiology is unknown; associated with abnormalities of intestinal motility and enhanced sensitivity to visceral stimuli
- The trigger may be luminal or environmental.
- Evidence for the role of small intestinal bacterial overgrowth (SIBO) in IBS and association with antibiotic therapy is controversial; older age and female gender are predictors of SIBO in IBS patients.
- The role of food sensitivity, genetic, and psychosocial causes are also under active investigation.
- Increase in mast cell density and activity has been demonstrated on biopsy from terminal ileum, jejunum, colon in patients with IBS, and may correlate with visceral hypersensitivity (1).
- Current investigation is ongoing regarding low-grade mucosal and neuroinflammation, and the contribution of this inflammation in the dysregulation of the “brain-gut” axis (1).
- Four bowel patterns in the Rome IV classification:
- IBS-D (diarrhea predominant), IBS-C (constipation predominant), IBS-M (mixed diarrhea and constipation, IBS-U (unclassified-symptoms cannot be categorized into one of the three subtypes)
- The utility of subtyping has been questioned. Many patients change categories/subtypes over time.
Genetics
Unknown. IBS tracks in some families. Twin studies do not, however, show a clear genetic component.
Risk Factors
- Other family members with similar GI disorder
- History of childhood sexual abuse
- Sexual/domestic abuse (primarily in women)
- Depression
- Anxiety
- GI infection
Pediatric Considerations
No risk to mother or fetus
General Prevention
See “Diet.”
Commonly Associated Conditions
- Chronic migraine
- Fibromyalgia
- Chronic fatigue syndrome
- Sleep disorders
- Psychiatric disorders: major depression, anxiety, somatoform disorders, and posttraumatic stress
- Chronic pelvic pain
- Temporomandibular joint dysfunction
There's more to see -- the rest of this entry is available only to subscribers.